Fast Breakthroughs for Cystic Fibrosis
Emily's Entourage (EE) is an innovative 501(c)3 foundation that funds research for new treatments and a cure for individuals in the final 10% of the cystic fibrosis (CF) community that do not benefit from existing mutation-targeted therapies, including those with nonsense mutations. CF is a fatal genetic disease primarily affecting the lungs and digestive system. Founded by Emily Kramer-Golinkoff, a woman with advanced stage CF, and her devoted friends and family, the organization has been featured in national media, including the New York Times, STAT, CNN, People, and more.
Since 2011, Emily’s Entourage has awarded millions of dollars in research grants, launched a now-acquired CF gene therapy company, developed a patient registry and clinical trial matchmaking program to accelerate clinical trial recruitment, and led worldwide efforts to drive high-impact research and drug development. The organization’s work is particularly critical now as revolutionary breakthroughs are available for roughly 90% of the CF population, but those in the outlying 10% that unfortunately do not benefit from these major advances. The work of EE is laser-focused on changing that — and doing it fast, so nobody is left behind
Cystic Fibrosis, Fundraising, Personalized Medicine, Healthcare Improvement, Innovative Drug Therapy, Grant Funding, Clinical Trials, Publications, and Lobbying
Emily's Entourage is a nonprofit organization that raises money and awareness to help find a cure for rare mutations of cystic fibrosis, a genetic disorder that generally affects a person's lungs and digestive system
Corporate | Type | Tweets | Articles | |
---|---|---|---|---|
Amgen Biotechnology, Biotechnology Research | Amgen Biotechnology, Biotechnology Research | Other 1 Mar 2024 | | |
MSD Pharmaceutical, Pharmaceutical Manufacturing | MSD Pharmaceutical, Pharmaceutical Manufacturing | Other 4 Jun 2019 | | |
Vertex Pharmaceuticals Biotechnology, Biotechnology Research | Vertex Pharmaceuticals Biotechnology, Biotechnology Research | Other 5 Dec 2017 28 Feb 2024 | | |
Intel Corporation IT services, Semiconductors, Semiconductor Manufacturing | Intel Corporation IT services, Semiconductors, Semiconductor Manufacturing | Other 14 Nov 2018 | | |
AbbVie Pharmaceutical, Pharmaceutical Manufacturing | AbbVie Pharmaceutical, Pharmaceutical Manufacturing | Other 15 Sep 2022 | | |
Boehringer Ingelheim Pharmaceutical, Pharmaceutical Manufacturing, Animal Health | Boehringer Ingelheim Pharmaceutical, Pharmaceutical Manufacturing, Animal Health | Other 7 Dec 2023 | |